Literature DB >> 28161763

The fibrous form of intracellular inclusion bodies in recombinant variant fibrinogen-producing cells is specific to the hepatic fibrinogen storage disease-inducible variant fibrinogen.

Shinpei Arai1,2, Naoko Ogiwara2, Saki Mukai2, Yuka Takezawa2, Mitsutoshi Sugano2, Takayuki Honda1, Nobuo Okumura3,4.   

Abstract

Fibrinogen storage disease (FSD) is a rare disorder that is characterized by the accumulation of fibrinogen in hepatocytes and induces liver injury. Six mutations in the γC domain (γG284R, γT314P, γD316N, the deletion of γG346-Q350, γG366S, and γR375W) have been identified for FSD. Our group previously established γ375W fibrinogen-producing Chinese hamster ovary (CHO) cells and observed aberrant large granular and fibrous forms of intracellular inclusion bodies. The aim of this study was to investigate whether fibrous intracellular inclusion bodies are specific to FSD-inducible variant fibrinogen. Thirteen expression vectors encoding the variant γ-chain were stably or transiently transfected into CHO cells expressing normal fibrinogen Aα- and Bβ-chains or HuH-7 cells, which were then immunofluorescently stained. Six CHO and HuH-7 cell lines that transiently produced FSD-inducible variant fibrinogen presented the fibrous (3.2-22.7 and 2.1-24.5%, respectively) and large granular (5.4-25.5 and 7.7-23.9%) forms of intracellular inclusion bodies. Seven CHO and HuH-7 cell lines that transiently produced FSD-non-inducible variant fibrinogen only exhibit the large granular form. These results demonstrate that transiently transfected variant fibrinogen-producing CHO cells and inclusion bodies of the fibrous form may be useful in non-invasive screening for FSD risk factors for FSD before its onset.

Entities:  

Keywords:  Fibrinogen storage disease; Hypofibrinogenemia; Immunofluorescence; Intracellular inclusion bodies; Recombinant fibrinogen

Mesh:

Substances:

Year:  2017        PMID: 28161763     DOI: 10.1007/s12185-017-2185-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  31 in total

1.  Hypofibrinogenemia associated with a heterozygous missense mutation gamma153Cys to arg (Matsumoto IV): in vitro expression demonstrates defective secretion of the variant fibrinogen.

Authors:  F Terasawa; N Okumura; K Kitano; N Hayashida; M Shimosaka; M Okazaki; S T Lord
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

2.  Familial hypodysfibrinogenaemia associated with second occurrence of gamma326 Cys-->Tyr mutation.

Authors:  Amy Dear; Stephen O Brennan; Peter M George
Journal:  Thromb Haemost       Date:  2005-03       Impact factor: 5.249

3.  Fibrinogen storage disease caused by Aguadilla mutation presenting with hypobeta-lipoproteinemia and considerable liver disease.

Authors:  Tsuyoshi Sogo; Hironori Nagasaka; Haruki Komatsu; Ayano Inui; Takashi Miida; Francesco Callea; Paola Francalanci; Ken-Ichi Hirano; Hajime Kitamura; Toru Yorifuji; Tomoo Fujisawa
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-07       Impact factor: 2.839

4.  Severely impaired polymerization of recombinant fibrinogen gamma-364 Asp --> His, the substitution discovered in a heterozygous individual.

Authors:  N Okumura; O V Gorkun; S T Lord
Journal:  J Biol Chem       Date:  1997-11-21       Impact factor: 5.157

Review 5.  Congenital fibrinogen disorders.

Authors:  Philippe de Moerloose; Marguerite Neerman-Arbez
Journal:  Semin Thromb Hemost       Date:  2009-07-13       Impact factor: 4.180

6.  Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency.

Authors:  Jeffrey H Teckman; Jae-Koo An; Keith Blomenkamp; Bela Schmidt; David Perlmutter
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-12-18       Impact factor: 4.052

Review 7.  Fibrinogen and fibrin structure and functions.

Authors:  M W Mosesson
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

8.  Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency.

Authors:  Matthew W Lawless; Catherine M Greene; Alan Mulgrew; Clifford C Taggart; Shane J O'Neill; Noel G McElvaney
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

9.  Autophagy-enhancing drug carbamazepine diminishes hepatocellular death in fibrinogen storage disease.

Authors:  Florian Puls; Imeke Goldschmidt; Heike Bantel; Clemens Agne; Verena Bröcker; Maximilian Dämmrich; Ulrich Lehmann; Jens Berrang; Eva-Doreen Pfister; Hans Heinrich Kreipe; Ulrich Baumann
Journal:  J Hepatol       Date:  2013-05-23       Impact factor: 25.083

10.  Hepatic fibrinogen storage disease due to the fibrinogen γ375 Arg → Trp mutation "fibrinogen Aguadilla" is present in Arabs.

Authors:  Abdulrahman Al-Hussaini; Abdulhadi Altalhi; Imad El Hag; Hussa AlHussaini; Paola Francalanci; Isabella Giovannoni; Francesco Callea
Journal:  Saudi J Gastroenterol       Date:  2014 Jul-Aug       Impact factor: 2.485

View more
  3 in total

1.  Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment.

Authors:  Masahiro Yoda; Takahiro Kaido; Tomu Kamijo; Chiaki Taira; Yumiko Higuchi; Shinpei Arai; Nobuo Okumura
Journal:  Int J Hematol       Date:  2021-06-12       Impact factor: 2.490

2.  Recombinant γY278H Fibrinogen Showed Normal Secretion from CHO Cells, but a Corresponding Heterozygous Patient Showed Hypofibrinogenemia.

Authors:  Tomu Kamijo; Takahiro Kaido; Masahiro Yoda; Shinpei Arai; Kazuyoshi Yamauchi; Nobuo Okumura
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

Review 3.  Protein Aggregation in the ER: Calm behind the Storm.

Authors:  Haisen Li; Shengyi Sun
Journal:  Cells       Date:  2021-11-28       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.